These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 19380407

  • 21. The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
    Goldschmidt N, Or O, Klein M, Savitsky B, Paltiel O.
    Ann Hematol; 2011 Feb; 90(2):165-71. PubMed ID: 20706721
    [Abstract] [Full Text] [Related]

  • 22. Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.
    Coha B, Radmilović K, Gardasanić J, Daković M, Stefanić M, Latić A, Mitrecić D.
    Acta Clin Croat; 2009 Mar; 48(1):35-9. PubMed ID: 19623870
    [Abstract] [Full Text] [Related]

  • 23. Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT.
    Sheehy N, Israel DA.
    Clin Nucl Med; 2007 Oct; 32(10):820-1. PubMed ID: 17885370
    [Abstract] [Full Text] [Related]

  • 24. A unique presentation of appendicitis: F-18 FDG PET/CT.
    Koff SG, Sterbis JR, Davison JM, Montilla-Soler JL.
    Clin Nucl Med; 2006 Nov; 31(11):704-6. PubMed ID: 17053390
    [Abstract] [Full Text] [Related]

  • 25. PET/CT in the management of haematological malignancies.
    Hutchings M, Specht L.
    Eur J Haematol; 2008 May; 80(5):369-80. PubMed ID: 18284629
    [Abstract] [Full Text] [Related]

  • 26. Role of early PET in the management of diffuse large B-cell lymphoma.
    Michallet AS, Trotman J, Tychyj-Pinel C.
    Curr Opin Oncol; 2010 Sep; 22(5):414-8. PubMed ID: 20683268
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Giant cell arteritis on 18F-FDG PET/CT.
    Heston TF, Szabo Z.
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):382-4. PubMed ID: 19522856
    [Abstract] [Full Text] [Related]

  • 29. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease.
    Nakajo M, Jinnouchi S, Noguchi M, Uozumi K, Tanabe H, Tateno R, Nakajo M.
    Clin Nucl Med; 2007 Apr; 32(4):282-5. PubMed ID: 17413574
    [Abstract] [Full Text] [Related]

  • 30. Neurolymphomatosis detected by (18)F-FDG PET/CT scan - a case report.
    Czepczyński R, Guzikowska-Ruszkowska I, Sowiński J.
    Nucl Med Rev Cent East Eur; 2008 Apr; 11(2):73-5. PubMed ID: 19585459
    [Abstract] [Full Text] [Related]

  • 31. Imaging of non-Hodgkin lymphomas: diagnosis and response-adapted strategies.
    El-Galaly TC, Hutchings M.
    Cancer Treat Res; 2015 Apr; 165():125-46. PubMed ID: 25655608
    [Abstract] [Full Text] [Related]

  • 32. The role of PET in lymphoma.
    Jhanwar YS, Straus DJ.
    J Nucl Med; 2006 Aug; 47(8):1326-34. PubMed ID: 16883013
    [Abstract] [Full Text] [Related]

  • 33. FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.
    Karam M, Ata A, Irish K, Feustel PJ, Mottaghy FM, Stroobants SG, Verhoef GE, Chundru S, Douglas-Nikitin V, Oliver Wong CY, Brepoels LM.
    Nucl Med Commun; 2009 Oct; 30(10):770-8. PubMed ID: 19657307
    [Abstract] [Full Text] [Related]

  • 34. F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
    Wiesenthal AA, Nguyen BD.
    Clin Nucl Med; 2007 Oct; 32(10):797-801. PubMed ID: 17885362
    [Abstract] [Full Text] [Related]

  • 35. Time-to-time correlation of high-risk atherosclerotic lesions identified with [(18)F]-FDG-PET/CT.
    Wassélius J, Larsson S, Jacobsson H.
    Ann Nucl Med; 2009 Jan; 23(1):59-64. PubMed ID: 19205839
    [Abstract] [Full Text] [Related]

  • 36. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
    Hallett WA, Maguire RP, McCarthy TJ, Schmidt ME, Young H.
    IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
    [Abstract] [Full Text] [Related]

  • 37. Massive thyroid involvement by marginal zone B cell NHL as demonstrated by 18F-FDG-PET/CT.
    Bertagna F, Sobic-Saranovic D, Obradovic V, Artiko V, Giubbini R, Alavi A.
    Hell J Nucl Med; 2009 Nov; 12(1):63. PubMed ID: 19330187
    [No Abstract] [Full Text] [Related]

  • 38. Interesting image. Incidental diagnosis of prostate cancer by F-18 FDG PET/CT.
    Monet A, Merino B, Lupo R.
    Clin Nucl Med; 2010 Jan; 35(1):34-5. PubMed ID: 20026972
    [No Abstract] [Full Text] [Related]

  • 39. Cyanide-induced parkinsonism and F-18 FDG PET/CT findings.
    Sarikaya I, Apaydin H, Topal U, Karaoglan O.
    Clin Nucl Med; 2006 Jun; 31(6):363-4. PubMed ID: 16714905
    [No Abstract] [Full Text] [Related]

  • 40. [18F]FDG-PET-CT for early monitoring of tumor response: when and why.
    Storto G, Nicolai E, Salvatore M.
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):167-80. PubMed ID: 19293765
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.